A seizure became a treatment target
In the early 20th century, psychiatrists had few treatments for severe psychosis. Ladislas Meduna’s observation—that epilepsy and schizophrenia appeared to be uncommon in the same people—suggested a bold possibility: perhaps the bodily changes accompanying a seizure could interrupt symptoms of schizophrenia.
The idea rested on an apparent pattern, not a known biological mechanism. Meduna reasoned that if the two conditions opposed each other, deliberately causing a seizure might help a patient. He began using camphor, a substance that could provoke convulsions, to test that hypothesis. The treatment was not a way of treating epilepsy; the seizure itself was the intended intervention.
From observation to induced convulsion
Camphor did not provide a precise switch. A seizure was a dramatic, difficult-to-control event, and provoking one exposed patients to substantial physical risks. The practice also depended on a theory of illness that was not established simply by noticing that two diagnoses seemed to overlap rarely.
Still, the attempt mattered in psychiatry’s history. It helped establish the idea that a deliberately induced seizure might have therapeutic effects, leading to other forms of convulsive treatment. Later methods, including electroconvulsive therapy, used different means to produce seizures under more controlled medical conditions; they should not be confused with Meduna’s camphor treatment.
The enduring consequence was not proof that schizophrenia and epilepsy are opposites. It was a new, consequential question for psychiatry: could a carefully induced change in brain activity alter severe mental symptoms?
